Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epstein Barr Virus in Immunosuppressed Host. Epstein Barr Virus = Human herpesvirus 4 Infects more than 95% of the world's population. Humans are the.

Similar presentations


Presentation on theme: "Epstein Barr Virus in Immunosuppressed Host. Epstein Barr Virus = Human herpesvirus 4 Infects more than 95% of the world's population. Humans are the."— Presentation transcript:

1 Epstein Barr Virus in Immunosuppressed Host

2 Epstein Barr Virus = Human herpesvirus 4 Infects more than 95% of the world's population. Humans are the only known reservoir of Epstein-Barr virus. EBV is present in oropharyngeal secretions and is most commonly transmitted through saliva. The virus replicates in nasopharyngeal epithelial cells. Viral replication  viremia  lymphoreticular system, including the liver, spleen, and B lymphocytes in peripheral blood. Host immune response to the viral infection includes activation of CD8+ T lymphocytes = atypical lymphocytes found in the peripheral blood. The T lymphocytes kill EBV-infected B cells and eventually reduce the number of Epstein-Barr virus–infected B lymphocytes to less than 1 per 106 circulating B cells. Latent viral infection of memory B cells

3 Clinical Manifestations Most commonly associated with infectious mononucleosis Classically affects adolescents and young adults Children often asymptomatic Self-limited course Classic triad of symptoms

4 Sore throat +/- tonsillar Exudate (85% of pts) Lymphadenopathy (usually posterior cervical chain) Present in ~100% of pts

5 Fever! – 98% of pts ** e.g. Saturday Night Fever

6 Splenomegaly – seen in 50% pts

7 Rash! Generalized maculopapular, urticarial or petechial rash Erythema nodosum has been reported, but is rare Rash more common in pts treated with antibiotics (esp. ampicillin or amoxicillin)

8 Reactive Lymphocytes! Lymphocytosis = most common lab finding Absolute count > 4500 Differential count > 50% Most pt’s have >10% atypical lymphocytes on peripheral smear = CD8+ Tcells

9 Less common manifestations of EBV “EBV can affect virtually any organ.” Hepatitis  Fulminant liver failure Jaundice is rare Glomerulonephritis/ Acute Kidney Injury Pneumonia/Pleural effusion Myocarditis Pancreatitis Myositis

10 Hepatitis! Increased infiltration by CD8+ T cells  Inflammation of the liver  Transaminitis

11 Neurologic syndromes Guillian-Barre Cranial nerve palsies Encephalitis Aseptic meningitis Transverse myelitis Optic neuritis

12 Oral Hairy Leukoplakia! Vs. Oral Candidiasis

13 Epstein-Barr virus serology Antibodies to Epstein-Barr virus antigens Antibodies to viral capsid antigen (VCA), early antigens (EAs) Epstein-Barr nuclear antigen (EBNA). Primary acute Epstein-Barr virus infection is associated with VCA-IgM, VCA-IgG, and absent EBNA antibodies. The antibody pattern in recent infection (3-12 mo) includes positive findings for VCA-IgG and EBNA antibodies, negative VCA-IgM antibodies, and, usually, positive EA antibodies. Patients who are immunocompromised and have persistent or reactivated Epstein-Barr virus infections often have high levels of antibodies to EA/D or EA/R.

14 Monospot Rapid slide agglutination tests, including Monospot assays, have been developed to measure acute infectious mononucleosis heterophile antibodies in a rapid qualitative fashion. Slide tests use either horse RBCs or bovine RBCs. All commercial kits for rapid diagnosis of acute infectious mononucleosis heterophile antibodies have low sensitivity (63-84%), with a negative predictive value of more than 10%. Spot tests rarely yield false-positive results in patients with lymphoma or hepatitis.

15 Treatment In most cases, no treatment is necessary ---------------------------------------------------- Corticosteroids for tonsillar edema / respiratory distress In vitro trials of acyclovir Our patient was treated with Valcyte 900mg po q day IVIG for immune-mediated thrombocytopenia

16 THE END


Download ppt "Epstein Barr Virus in Immunosuppressed Host. Epstein Barr Virus = Human herpesvirus 4 Infects more than 95% of the world's population. Humans are the."

Similar presentations


Ads by Google